5938Mortality risk stratification in patients with severe tricuspid regurgitation - Insights from the Tricuspid Regurgitation REgistry (TRuE)
Brunilda Alushi(Deutsches Herzzentrum der Charité), Alexander Lauten(German Centre for Cardiovascular Research), Muhammad Jamaluddin(Charité - Universitätsmedizin Berlin), Azeem Latib(Albert Einstein College of Medicine), Rebecca T. Hahn(Columbia University Irving Medical Center), Herko Grubitzch(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Frederik Beckhoff(German Centre for Cardiovascular Research), Ulf Landmesser(Deutsches Herzzentrum der Charité), B E Staehli(University Hospital Zurich), David M. Leistner(University of Salzburg), Boris Bigalke(Charité - Universitätsmedizin Berlin), Volkmar Falk(ETH Zurich)
Cited by 3
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k